BioCentury
ARTICLE | Company News

Elan autoimmune news

March 5, 2012 8:00 AM UTC

Elan said CEO Kelly Martin will not step down on May 1 as previously announced. Chairman Robert Ingram said in a statement that he asked Kelly to remain as CEO until data from Phase III trials of bapi...